Treatment of the postoperative recurrence of lung cancer in octogenarians

Manabu Yasuda, Akira Nagashima, Akira Haro, Genkichi Saitoh

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose: Guidelines for the treatment of postoperative recurrent lung cancer in octogenarians do not exist. In this study, we investigated the prognosis of patients with recurrence after the resection of lung cancer and discuss the management of recurrent tumors in octogenarians. Methods: This study clinicopathologically evaluated 135 octogenarians who underwent resections for lung cancer at a single institution between 1992 and 2010. We retrospectively reviewed the clinical records of 37 patients with confirmed recurrence. The overall survival of the patients and the treatments used for postoperative recurrence were evaluated. Results: Among 37 patients, six underwent intensive treatment, 14 underwent palliative treatment and 17 received supportive care only. The overall survival rates of the patients in the antitumor treatment groups tended to be associated with a better prognoses than those of the patients in the supportive care only group, but they did not exhibit significantly better prognoses at 1 year (p = 0.202). However, among the patients with a good performance status, the intensive treatment group tended to exhibit prolonged survival. Of the 37 patients with recurrent tumors, five (14 %) died of other diseases. Conclusions: Antitumor treatment of postoperative recurrent lung cancer in octogenarians may not always improve the survival rate. However, carefully selecting patients for intensive therapy, such as those with a good performance status, may lead to longer survival rates after postoperative recurrence in octogenarians.

Original languageEnglish
Pages (from-to)1626-1632
Number of pages7
JournalSurgery today
Volume44
Issue number9
DOIs
Publication statusPublished - Sep 2014

Fingerprint

Lung Neoplasms
Recurrence
Therapeutics
Survival Rate
Survival
Palliative Care
Neoplasms
Guidelines

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Treatment of the postoperative recurrence of lung cancer in octogenarians. / Yasuda, Manabu; Nagashima, Akira; Haro, Akira; Saitoh, Genkichi.

In: Surgery today, Vol. 44, No. 9, 09.2014, p. 1626-1632.

Research output: Contribution to journalArticle

Yasuda, M, Nagashima, A, Haro, A & Saitoh, G 2014, 'Treatment of the postoperative recurrence of lung cancer in octogenarians', Surgery today, vol. 44, no. 9, pp. 1626-1632. https://doi.org/10.1007/s00595-013-0719-x
Yasuda, Manabu ; Nagashima, Akira ; Haro, Akira ; Saitoh, Genkichi. / Treatment of the postoperative recurrence of lung cancer in octogenarians. In: Surgery today. 2014 ; Vol. 44, No. 9. pp. 1626-1632.
@article{5ef80007346f45bcb2145cac55dbfe1d,
title = "Treatment of the postoperative recurrence of lung cancer in octogenarians",
abstract = "Purpose: Guidelines for the treatment of postoperative recurrent lung cancer in octogenarians do not exist. In this study, we investigated the prognosis of patients with recurrence after the resection of lung cancer and discuss the management of recurrent tumors in octogenarians. Methods: This study clinicopathologically evaluated 135 octogenarians who underwent resections for lung cancer at a single institution between 1992 and 2010. We retrospectively reviewed the clinical records of 37 patients with confirmed recurrence. The overall survival of the patients and the treatments used for postoperative recurrence were evaluated. Results: Among 37 patients, six underwent intensive treatment, 14 underwent palliative treatment and 17 received supportive care only. The overall survival rates of the patients in the antitumor treatment groups tended to be associated with a better prognoses than those of the patients in the supportive care only group, but they did not exhibit significantly better prognoses at 1 year (p = 0.202). However, among the patients with a good performance status, the intensive treatment group tended to exhibit prolonged survival. Of the 37 patients with recurrent tumors, five (14 {\%}) died of other diseases. Conclusions: Antitumor treatment of postoperative recurrent lung cancer in octogenarians may not always improve the survival rate. However, carefully selecting patients for intensive therapy, such as those with a good performance status, may lead to longer survival rates after postoperative recurrence in octogenarians.",
author = "Manabu Yasuda and Akira Nagashima and Akira Haro and Genkichi Saitoh",
year = "2014",
month = "9",
doi = "10.1007/s00595-013-0719-x",
language = "English",
volume = "44",
pages = "1626--1632",
journal = "Surgery Today",
issn = "0941-1291",
publisher = "Springer Japan",
number = "9",

}

TY - JOUR

T1 - Treatment of the postoperative recurrence of lung cancer in octogenarians

AU - Yasuda, Manabu

AU - Nagashima, Akira

AU - Haro, Akira

AU - Saitoh, Genkichi

PY - 2014/9

Y1 - 2014/9

N2 - Purpose: Guidelines for the treatment of postoperative recurrent lung cancer in octogenarians do not exist. In this study, we investigated the prognosis of patients with recurrence after the resection of lung cancer and discuss the management of recurrent tumors in octogenarians. Methods: This study clinicopathologically evaluated 135 octogenarians who underwent resections for lung cancer at a single institution between 1992 and 2010. We retrospectively reviewed the clinical records of 37 patients with confirmed recurrence. The overall survival of the patients and the treatments used for postoperative recurrence were evaluated. Results: Among 37 patients, six underwent intensive treatment, 14 underwent palliative treatment and 17 received supportive care only. The overall survival rates of the patients in the antitumor treatment groups tended to be associated with a better prognoses than those of the patients in the supportive care only group, but they did not exhibit significantly better prognoses at 1 year (p = 0.202). However, among the patients with a good performance status, the intensive treatment group tended to exhibit prolonged survival. Of the 37 patients with recurrent tumors, five (14 %) died of other diseases. Conclusions: Antitumor treatment of postoperative recurrent lung cancer in octogenarians may not always improve the survival rate. However, carefully selecting patients for intensive therapy, such as those with a good performance status, may lead to longer survival rates after postoperative recurrence in octogenarians.

AB - Purpose: Guidelines for the treatment of postoperative recurrent lung cancer in octogenarians do not exist. In this study, we investigated the prognosis of patients with recurrence after the resection of lung cancer and discuss the management of recurrent tumors in octogenarians. Methods: This study clinicopathologically evaluated 135 octogenarians who underwent resections for lung cancer at a single institution between 1992 and 2010. We retrospectively reviewed the clinical records of 37 patients with confirmed recurrence. The overall survival of the patients and the treatments used for postoperative recurrence were evaluated. Results: Among 37 patients, six underwent intensive treatment, 14 underwent palliative treatment and 17 received supportive care only. The overall survival rates of the patients in the antitumor treatment groups tended to be associated with a better prognoses than those of the patients in the supportive care only group, but they did not exhibit significantly better prognoses at 1 year (p = 0.202). However, among the patients with a good performance status, the intensive treatment group tended to exhibit prolonged survival. Of the 37 patients with recurrent tumors, five (14 %) died of other diseases. Conclusions: Antitumor treatment of postoperative recurrent lung cancer in octogenarians may not always improve the survival rate. However, carefully selecting patients for intensive therapy, such as those with a good performance status, may lead to longer survival rates after postoperative recurrence in octogenarians.

UR - http://www.scopus.com/inward/record.url?scp=84906790442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906790442&partnerID=8YFLogxK

U2 - 10.1007/s00595-013-0719-x

DO - 10.1007/s00595-013-0719-x

M3 - Article

C2 - 24026198

AN - SCOPUS:84906790442

VL - 44

SP - 1626

EP - 1632

JO - Surgery Today

JF - Surgery Today

SN - 0941-1291

IS - 9

ER -